BioMarin Pharmaceutical
BMRN
#1978
Rank
ยฃ7.59 B
Marketcap
ยฃ39.31
Share price
-1.48%
Change (1 day)
-17.47%
Change (1 year)

BioMarin Pharmaceutical (BMRN) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : ยฃ1.11 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's total liabilities are ยฃ1.11 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BioMarin Pharmaceutical - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31ยฃ1.11 B5.51%
2024-12-31ยฃ1.06 B-28.51%
2023-12-31ยฃ1.48 B1.29%
2022-12-31ยฃ1.46 B13.68%
2021-12-31ยฃ1.28 B0.81%
2020-12-31ยฃ1.27 B6.9%
2019-12-31ยฃ1.19 B4%
2018-12-31ยฃ1.14 B-14.84%
2017-12-31ยฃ1.34 B32.47%
2016-12-31ยฃ1.01 B13.67%
2015-12-31ยฃ0.89 B47.31%
2014-12-31ยฃ0.60 B11.17%
2013-12-31ยฃ0.54 B60.13%
2012-12-31ยฃ0.34 B-0.24%
2011-12-31ยฃ0.34 B-2.99%
2010-12-31ยฃ0.35 B-3.92%
2009-12-31ยฃ0.36 B-14.47%
2008-12-31ยฃ0.42 B36.08%
2007-12-31ยฃ0.31 B79.02%
2006-12-31ยฃ0.17 B11.56%
2005-12-31ยฃ0.15 B0.9%
2004-12-31ยฃ0.15 B102.48%
2003-12-31ยฃ77.41 M928.18%
2002-12-31ยฃ7.52 M-10.97%
2001-12-31ยฃ8.45 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Sanofi
SNY
ยฃ47.83 B 4,194.68%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
ยฃ1.18 B 6.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
ยฃ60.9 M-94.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
ยฃ0.60 B-45.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
ยฃ0.49 B-55.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
ยฃ0.11 B-90.07%๐Ÿ‡บ๐Ÿ‡ธ USA